Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    17233817 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Combination Chemotherapy in Treating Patients With Multiple Myeloma
Condition: Multiple Myeloma and Plasma Cell Neoplasm
Interventions: Drug: dexamethasone;   Drug: melphalan;   Drug: prednisone

Indicates status has not been verified in more than two years